UFPT on Nasdaq

UFP Technologies

American health care product manufacturer

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP Technologies manufactures a wide range of single-use medical devices, components, and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.3 Its shares trade on Nasdaq under the symbol UFPT.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1963Founded1

Compare with Bioventus Inc., NovoCure Ltd or AtriCure (United States), or pick any stock.

  • TickerUFPT on Nasdaq1
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersGeorgetown1
  • Websitewww.ufpt.com
  • Legal formDelaware corporation1
  • Incorporated inDE5
  • Business address100 Hale Street, Newburyport, Ma 019505
  • Filer categoryLarge accelerated filer5
  • LEI549300RJ8LY41HS70C914
  • StatusActive4
  • LEI statusLapsed (not renewed)4
  • Registered address251 LITTLE FALLS DRIVE, 19808 Wilmington, United States4
  • Registered withDivision of Corporations, Department of State, 23553794
UFPT Logo CMYK -«
Photo: Jbodoh, CC BY-SA 4.0, via Wikimedia Commons8

UFP Technologies, Inc. is an American multinational developer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

28.3%Gross margin9
15.3%Operating margin9
11.3%Net margin9
19.5%Revenue growth, 20259
16.1%Return on equity9
0.29×Debt to equity9

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Product brought in 98% of the revenue UFP Technologies broke down this way in fiscal 2025.

  1. Product$591.4M998%up 20% from 2024
  2. Engineering And Development$6.9M91%up 47% from 2024
  3. Tooling And Machinery$4.5M91%down 46% from 2024
Products and services by year
Products and services202320242025
Product$391.5M$491.4M$591.4M
Engineering And Development$5.1M$4.7M$6.9M
Tooling And Machinery$3.5M$8.3M$4.5M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue72¢$432.4M
  • Research and development1¢$8.6M
  • Selling, general and admin13¢$77.4M
  • Income tax2¢$14.2M
  • Profit11¢$68.3M

Out of $602.8M in revenue.9

Where each dollar of operating cash went, fiscal 2025

  • Kept or used elsewhere100¢$91.9M

Out of $91.9M of cash from operations.9

Financial statements

Revenue101112139$602.8M in 2025+204% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $198.4M$198.4M20192020: $179.4M$179.4M2020−10%2021: $206.3M$206.3M2021+15%2022: $353.8M$353.8M2022+71%2023: $400.1M$400.1M2023+13%2024: $504.4M$504.4M2024+26%2025: $602.8M$602.8M2025+20%
Gross profit101112139$170.4M in 2025+216% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $54.0M$54.0M20192020: $44.7M$44.7M2020−17%2021: $51.1M$51.1M2021+14%2022: $90.3M$90.3M2022+77%2023: $112.2M$112.2M2023+24%2024: $146.7M$146.7M2024+31%2025: $170.4M$170.4M2025+16%
Operating income101112139$92.3M in 2025+274% since 2019
0$25.0M$50.0M$75.0M$100.0M2019: $24.7M$24.7M20192020: $16.7M$16.7M2020−32%2021: $21.2M$21.2M2021+27%2022: $55.4M$55.4M2022+161%2023: $57.7M$57.7M2023+4%2024: $80.9M$80.9M2024+40%2025: $92.3M$92.3M2025+14%
Net income101112139$68.3M in 2025+246% since 2019
0$20.0M$40.0M$60.0M$80.0M2019: $19.8M$19.8M20192020: $13.4M$13.4M2020−32%2021: $15.9M$15.9M2021+19%2022: $41.8M$41.8M2022+163%2023: $44.9M$44.9M2023+8%2024: $59.0M$59.0M2024+31%2025: $68.3M$68.3M2025+16%

Every line of the income statement as filed: the last 3 fiscal years (annual) or 12 quarters (quarterly), latest first.9

Period ending2025-12-312024-12-312023-12-31
Net sales$602.8M$504.4M$400.1M
Cost of sales$432.4M$357.7M$287.8M
Gross profit$170.4M$146.7M$112.2M
Selling, general, and administrative expenses$77.4M$62.2M$50.9M
Acquisition costs$334.0K$2.5M$0
Change in fair value of contingent consideration$261.0K$952.0K$3.5M
Loss on disposal of property, plant and equipment$38.0K$106.0K$145.0K
Operating income$92.3M$80.9M$57.7M
Interest expense, net$9.8M$8.1M$3.6M
Other expense (income)$21.0K-$189.0K$117.0K
Income before income tax provision$82.5M$73.0M$53.9M
Income tax expense$14.2M$14.0M$9.0M
Basic (in dollars per share)$8.87$7.69$5.89
Diluted (in dollars per share)$8.75$7.58$5.83
Basic (in shares)7.7M shares7.7M shares7.6M shares
Diluted (in shares)7.8M shares7.8M shares7.7M shares
Net income$68.3M$59.0M$44.9M
Foreign currency translation adjustment$7.9M-$4.4M$878.0K
Other comprehensive income (loss)$7.9M-$4.4M$878.0K
Comprehensive income$76.2M$54.5M$45.8M

Compare UFP Technologies with another company

Corporate structure

UFP Technologies sits at the top of its group. 4 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of UFP Technologies

  • UFP Technologies Newburyport, Massachusetts, United States
    • 2. Advant Costa Rica Limitada, incorporated under the laws of Subsidiary · Costa Rica
    • A. AQF Asia Sdn Bhd., a private registered trading entity organized under the laws of Subsidiary · Malaysia
    • a. Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Subsidiary · Ireland

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What UFP Technologies reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$152.5M9 Dec 31, 2025$134.9M9 Dec 31, 2024+13.0%
Accumulated depreciation$73.3M9 Dec 31, 2025$64.4M9 Dec 31, 2024+13.9%
Property and equipment, net$79.1M9 Dec 31, 2025$70.6M9 Dec 31, 2024+12.1%
Finance-lease assets$32.0K9 Dec 31, 2025$92.0K9 Dec 31, 2024−65.2%
Operating-lease assets (leased space)$18.8M9 Dec 31, 2025$16.1M9 Dec 31, 2024+17.4%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$20.3M9 Dec 31, 2025$13.4M9 Dec 31, 2024+50.9%
Stakes in other companies (equity method)$6.9M9 Dec 31, 2025$6.8M9 Dec 31, 2024+1.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$197.4M9 Dec 31, 2025$189.7M9 Dec 31, 2024+4.1%
Intangible assets, net (excluding goodwill)$140.8M9 Dec 31, 2025$144.3M9 Dec 31, 2024−2.4%
Finite-lived intangibles, gross$171.2M9 Dec 31, 2025$164.7M9 Dec 31, 2024+3.9%
Accumulated amortization$30.4M9 Dec 31, 2025$20.5M9 Dec 31, 2024+48.4%
Finite-lived intangibles, net$140.8M9 Dec 31, 2025$144.3M13 Dec 31, 2024−2.4%

Inventory

ItemLatestA year beforeChange
Inventory, total$86.9M9 Dec 31, 2025$87.5M9 Dec 31, 2024−0.8%
Raw materials$68.1M9 Dec 31, 2025$65.5M9 Dec 31, 2024+3.9%
Work in process$3.9M9 Dec 31, 2025$6.0M9 Dec 31, 2024−34.6%
Finished goods$14.9M9 Dec 31, 2025$16.1M9 Dec 31, 2024−7.4%

Properties, in its own words

The following table presents certain information relating to each of the Company’s design and manufacturing properties:

Location · SquareFeet · LeaseExpiration Date · Principal Use

The rest of Item 2

Newburyport, Massachusetts · 183,000 · Company Owned · Headquarters, fabrication, molding, tooling, test lab, clean room, warehousing, and engineering

Grand Rapids, Michigan · 255,260 · Company Owned · Fabrication, molding, warehousing, and engineering

St. Charles, Illinois · 177,891 · 6/30/2029 · Distribution, manufacturing, and warehousing

El Paso, Texas · 127,730 · Company Owned · Warehousing, fabrication

Chicopee, Massachusetts · 103,792 · Company Owned · Fabrication, molding, clean room, warehousing, and engineering

Tijuana, Mexico · 83,526 · 2/28/2032 · Fabrication, molding, and warehousing

Providence, Rhode Island · 79,535 · 9/30/2028 · Fabrication, molding, clean room, and warehousing

La Romana, Dominican Republic · 56,265 · 12/31/2029 · Fabrication, molding, clean room, and warehousing

Rancho Dominguez, California · 56,000 · 10/31/2027 · Fabrication, molding and engineering

La Romana, Dominican Republic · 51,970 · 8/31/2030 · Fabrication, molding, clean room, and warehousing

Santiago Norte, Dominican Republic · 49,425 · 12/16/2029 · Distribution, manufacturing, and warehousing

Kissimmee, Florida · 49,400 · Company Owned · Fabrication, molding, test lab and engineering

La Romana, Dominican Republic · 40,921 · 12/31/2028 · Fabrication, molding, clean room, and warehousing

Navan, Ireland · 40,000 · 10/6/2041 · Distribution, manufacturing, and warehousing

Santiago Norte, Dominican Republic · 39,414 · 12/1/2029 · Distribution, manufacturing, and warehousing

Galway, Ireland · 35,069 · Company Owned · Fabrication, molding, clean room, and warehousing

Añasco, Puerto Rico · 32,210 · 2/28/2027 · Manufacturing and clean room

Denver, Colorado · 28,383 · Company Owned · Fabrication, molding and engineering

La Romana, Dominican Republic · 26,468 · 12/31/2025 · Fabrication, molding, clean room, and warehousing

Dover, New Hampshire · 22,500 · Company Owned · Distribution, manufacturing, and warehousing

Denver, Colorado · 18,270 · Company Owned · Fabrication and molding

La Romana, Dominican Republic · 16,557 · 12/31/2028 · Fabrication, molding, clean room, and warehousing

La Romana, Dominican Republic · 15,266 · 12/31/2026 · Fabrication, molding, clean room, and warehousing

La Aurora, Heredia, Costa Rica · 15,069 · 12/19/2027 · Fabrication, molding, clean room, and warehousing

Dover, New Hampshire · 14,400 · 1/31/2027 · Distribution, manufacturing, and warehousing

La Aurora, Heredia, Costa Rica · 14,200 · 8/31/2030 · Fabrication, molding, clean room, and warehousing

Tallahassee, Florida · 12,000 · Company Owned · Distribution, manufacturing, and warehousing

Galway, Ireland · 11,500 · 12/31/2025 · Fabrication, molding, clean room, and warehousing

Kennesaw, Georgia · 11,017 · 12/31/2027 · Warehousing

Rockville, Maryland · 9,291 · 7/31/2027 · Fabrication and molding

Huntsville, Alabama · 9,000 · 6/30/2031 · Engineering, design, and fabrication

La Romana, Dominican Republic · 4,209 · 5/31/2032 · Meeting rooms and offices

La Romana, Dominican Republic · 56,265 · 12/31/2029 · Fabrication, molding, clean room, and warehousing

Item 2 of the 10-K filed Feb 27, 2026.17

The story

1963-1975

United Packaging Corporation was founded in 1963 by William H. Shaw, Robert W. Drew, and Richard L. Bailly in Woburn, MA as a manufacturer of protective packaging, primarily for electronics. In 1964, the company expanded operations and moved its factory headquarters to Georgetown, Massachusetts. In 1967, the company changed its name to United Foam Plastics Corporation to reflect a broader market capability.

1976-1983

In 1976, with a focus on foam fabrication, the company started precision molding cross-linked polyethylene foam components for the military, consumer, and industrial markets.

1984-1993

In 1988 UFP Technologies introduced compression molded medical protective packaging using specialized foams. On December 17, 1993 the company completed its IPO and formally changed its name to UFP Technologies, Inc. Acquisitions brought new, highly specialized materials including various foams, films, and fabrics used in a range of medical, military, aerospace, consumer, and automotive applications. Additionally, UFP added molded pulp packaging to its portfolio through the acquisition of Moulded Fibre Technology out of Portland, ME.

1994-2003

UFP's growing medical customer base prompted its investment in cleanroom production starting in 1994. In 2001 the company introduced thermoplastic polyurethane (TPU) based pouches and bags as an alternative to foam packaging for the orthopedic implant market. Additional acquisitions expanded its medical foams access and capabilities for a range of applications.

Read the full text

2004-2013

UFP continued to focus on the medical market, accounting for 50% of its $100 million revenue by 2008. Between 2008 and 2013, UFP made five acquisitions to continue its foam offering to medical clients. In 2013 the company introduced a new product line called FlexShield®, a TPU based packaging solution for medical devices, instruments, and orthopedic implants.

2014-2024

In 2016 UFP expanded operations and relocated its headquarters to Newburyport, Massachusetts. In 2022 UFP Technologies sold Molded Fiber Business to CKF, Inc.

In 2022 Sales exceeded $300 million and the firm opened a new medical manufacturing operation in Tijuana, Mexico. In 2023, UFP Technologies was added to the S&P SmallCap 600 index. Additional MedTech acquisitions expanded UFP's international footprint to 5 countries and added complete device manufacturing capabilities. As of 2024, its MedTech business accounted for over 90% of revenue.

From Wikipedia’s article on UFP Technologies, shared under CC BY-SA 4.0.6

Leadership

Who has led UFP Technologies, and when. Pick a name to see everywhere that person has worked.

Chief financial officer

  1. Ronald J. Lataille2006–now
197019801990200020102020
Board members and other officers (18)

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

  • 2. Advant Costa Rica Limitada, incorporated under the laws of Costa Rica7
  • A. AQF Asia Sdn Bhd., a private registered trading entity organized under the laws of Malaysia7
  • a. Munlu Leighis Advant Teoranta, a private limited company incorporated under the laws of Ireland7

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Acquisitions

1993 - Moulded Fibre Technology

1997 - FCE Industries

1998 - Pacific Foam Technologies

2000 – Simco Industries

Read the full text

2008 - Stephenson & Lawyer

2009 - Advanced Materials Group

2009 - Foamade Industries Inc.

2009 - E.N. Murray

2013 - Packaging Alternatives Corporation

2018 – Dielectrics

2021 - Contech Medical

2021 – DAS Medical

2022 - Advant Medical

2024 - AJR Enterprises

2024 - AQF Medical

2024 - Marble Medical

2024 - Welch Fluorocarbon

2025 - UNIPEC

2025 - Techno Plastics Industries, Inc. (TPI)

From Wikipedia’s article on UFP Technologies, shared under CC BY-SA 4.0.6

Timeline

  1. Aug 24, 20268-K Regulation FD disclosure38
  2. Aug 3, 20268-K Results of operations39
  3. Jun 10, 20268-K Executive or director change; Regulation FD disclosure40
  4. Jun 8, 20268-K Regulation FD disclosure41
  5. Jun 5, 20268-K Shareholder vote42
  6. May 26, 20268-K Executive or director change43
  7. May 4, 20268-K Results of operations44
  8. Feb 27, 20268-K Regulation FD disclosure45
  9. Feb 24, 20268-K Results of operations46
  10. Feb 24, 20268-K Cybersecurity incident47
  11. Feb 24, 20268-K Entered a material agreement48
  12. Feb 13, 20268-K Executive or director change49
  13. Jan 4, 2006New chief executive R. Jeffrey Bailly becomes CEO18
  14. Dec 17, 1993Went public Listed on NASDAQ1
  15. 1963Founded Founded1

Calendar

Coming up

  1. Nov 2, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported $2.39 a share, on Nov 3, 2025.50

When it reported results

  1. Aug 3, 2026Reported quarterly or annual results39
  2. May 4, 2026Reported quarterly or annual results44
  3. Feb 24, 2026Reported quarterly or annual results46
  4. Nov 3, 2025Reported quarterly or annual results51
  5. Aug 5, 2025Reported quarterly or annual results52
  6. May 7, 2025Reported quarterly or annual results53
  7. Feb 25, 2025Reported quarterly or annual results54
  8. Nov 12, 2024Reported quarterly or annual results55

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

336 filings to the SEC since October 2021: 5 annual reports, 16 quarterly reports, 64 major events, 173 insider forms, 28 large holders, 50 other. The latest 20:

  1. Oct 9, 2026SCHEDULE 13G/A EDGAR
  2. Aug 27, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  3. Aug 25, 2026144 EDGAR
  4. Aug 24, 20268-K 8-K RE INVESTOR PRESENTATION EDGAR
  5. Aug 19, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  6. Aug 17, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  7. Aug 17, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  8. Aug 17, 2026144/A EDGAR
  9. Aug 14, 2026144 EDGAR
  10. Aug 13, 2026144 EDGAR
  11. Aug 12, 20264/A EDGAR
  12. Aug 11, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  13. Aug 10, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  14. Aug 7, 20264 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES EDGAR
  15. Aug 6, 2026144 EDGAR
  16. Aug 6, 2026144 EDGAR
  17. Aug 6, 202610-Q EDGAR
  18. Aug 6, 2026144 EDGAR
  19. Aug 3, 20268-K EDGAR
  20. Jul 31, 2026SCHEDULE 13G EDGAR

The 336 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

72 open-market trades by officers, directors and large owners since October 2021: 3 buys and 69 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Aug 25, 2026KOZIN MARC DDirectorSale7,000$304.50$2.1MForm 4
Aug 18, 2026Hudson SymeriaDirectorSale298$319.11$95.1KForm 4
Aug 14, 2026Hudson SymeriaDirectorSale1,926$324.58$625.1KForm 4
Aug 13, 2026FELDMANN CYNTHIA LDirectorSale1,000$324.26$324.3KForm 4
Aug 10, 2026BAILLY R JEFFREYExecutive ChairmanSale13,011$316.13$4.1MForm 4
Aug 7, 2026BAILLY R JEFFREYExecutive ChairmanSale5,013$317.87$1.6MForm 4
Aug 6, 2026BAILLY R JEFFREYExecutive ChairmanSale10,682$318.63$3.4MForm 4
Aug 6, 2026Holt JasonVice PresidentSale1,100$317.00$348.7KForm 4
Jun 12, 2026FELDMANN CYNTHIA LDirectorSale1,200$239.29$287.1KForm 4
May 12, 2026CROTEAU DANIEL CDirectorSale2,864$221.71$635.0KForm 4
Dec 10, 2025Holt JasonVice PresidentSale100$213.58$21.4KForm 4
Nov 6, 2025Litterio Christopher P.Senior Vice PresidentSale1,829$227.20$415.6KForm 4
Sep 5, 2025CROTEAU DANIEL CDirectorSale2,873$206.02$591.9KForm 4
May 8, 2025Litterio Christopher P.Senior Vice PresidentSale1,473$220.12$324.2KForm 4
Feb 28, 2025FELDMANN CYNTHIA LDirectorSale2,756$230.72$635.9KForm 4
Feb 27, 2025CROTEAU DANIEL CDirectorSale6,846$228.41$1.6MForm 4
Feb 27, 2025LATAILLE RONALD JChief Financial OfficerBuy400$229.09$91.6KForm 4
Nov 13, 2024BAILLY R JEFFREYExecutive ChairmanSale2,488$345.70$860.1KForm 4
Nov 12, 2024Holt JasonVice PresidentSale146$342.69$50.0KForm 4
Nov 12, 2024BAILLY R JEFFREYExecutive ChairmanSale12,533$346.46$4.3MForm 4

All 72 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

YearExecutiveAgeSalaryTotal pay
2025R. Jeffrey Bailly$789.0K$7.6M66
2025Mitchell C. Rock58$525.0K$2.6M66
2025Ronald J. Lataille64$485.0K$2.5M66
2025Christopher P. Litterio63$385.0K$1.2M66
2025Jason Holt52$352.0K$980.8K66
2024Chief Executive Officer$705.0K$5.3M66
2024President$500.0K$1.8M66
2024Senior Vice PresidentTreasurer, and Chief Financial Officer$460.0K$1.6M66
2024General CounselSecretary, and Senior Vice President of Human Resources$370.0K$939.4K66
2024Senior VicePresident$338.0K$743.9K66
2023Chief Executive Officer$680.0K$4.9M66
2023Senior Vice PresidentTreasurer, and Chief Financial Officer$440.0K$1.5M66
2023President$440.0K$1.5M66
2023General CounselSecretary, and Senior Vice President of Human Resources$355.0K$912.5K66
2023Senior VicePresident$325.0K$722.8K66

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
BlackRock, Inc.1,141,410$302.6M0.0%+44,227
Congress Asset Management Co687,439$182.3M1.1%+164,001
Wasatch Advisors LP683,262$181.2M1.2%−94,051
Neuberger Berman Group LLC537,038$142.4M0.1%+236,445
Boston Trust Walden Corp336,278$89.2M0.7%+19,206
Vanguard Capital Management LLC329,623$87.4M0.0%+2,898
State Street Corp312,811$82.9M0.0%+9,498
American Century Companies Inc279,976$74.2M0.0%+154,116
UBS Group AG254,740$67.5M0.0%+81,000
Massachusetts Financial Services Co /ma/223,474$59.2M0.0%−3,829
Geode Capital Management, LLC200,933$53.3M0.0%+10,313
Allspring Global Investments Holdings, LLC195,720$52.6M0.1%+5,857
Dimensional Fund Advisors LP186,313$49.4M0.0%+6,340
Vanguard Portfolio Management LLC161,218$42.7M0.0%+9,457
AltraVue Capital, LLC147,466$39.1M2.8%−6,600
Annex Advisory Services, LLC130,481$34.6M0.6%+87
Morgan Stanley124,387$33.0M0.0%−4,193
Franklin Resources Inc114,068$30.2M0.0%+31,920
Swedbank AB105,505$28.0M0.0%−9,500
Ashford Capital Management Inc105,020$27.8M3.0%−2,990
Geneva Capital Management LLC103,038$27.3M0.6%−28,135
Envestnet Asset Management Inc98,347$26.1M0.0%−11,444
Northern Trust Corp91,260$24.2M0.0%+4,860
Neumeier Poma Investment Counsel LLC84,575$22.4M1.5%+33,720
Renaissance Technologies LLC84,465$22.4M0.0%−22,007

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How UFP Technologies is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARUFP TECHNOLOGIES INC2
  • CIK0000914156
  • Employer ID (EIN)04-231497017
  • Filer statusLarge accelerated filer not an emerging growth company; not a smaller reporting company; not a shell company17
  • Incorporated inDelaware17
  • Fiscal year endsDecember 312
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus2
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance2
  • Business address100 Hale Street, Newburyport, MA 019502
  • Phone978-352-22002
  • Shares outstanding7,745,790 as of Jul 27, 202615
  • Public float$1.8B as of Jun 30, 202517
  • AuditorGRANT THORNTON LLP, Boston, Massachusetts PCAOB ID 248; no auditor attestation of internal control over financial reporting17
  • On EDGAR sinceFeb 5, 19962
  • Filings1,581 in all: 4 (884), 8-K (207), SC 13G/A (118), 10-Q (92), SC 13G (37), 4/A (32), 10-K (30), 144 (30)2
    All 29 form types

    DEF 14A (30), ARS (15), 3 (14), SC 13D/A (14), SD (13), UPLOAD (10), S-8 (9), SC 13D (7), SCHEDULE 13G/A (6), 8-K/A (5), CORRESP (5), 5 (4), DEFR14A (3), PRE 14A (3), S-8 POS (3), SCHEDULE 13G (3), 144/A (2), 8-A12G (2), 10-K/A (1), 10-Q/A (1), 8-A12B (1)

  • Latest filingsAnnual report (10-K) Feb 27, 2026
    Quarterly report (10-Q) Aug 6, 2026
    Proxy statement (DEF 14A) Apr 30, 2026
    Latest 8-K (8-K) Aug 24, 2026

Securities registered for trading

ClassSymbolExchange
Common StockUFPTNASDAQ

From the cover page of the 10-K filed Feb 27, 2026 (Section 12(b) of the Exchange Act).17

Risk factors and legal proceedings

The risks UFP Technologies names in Item 1A of its 10-K filed Feb 27, 2026: 35 risks under these headings, as written.17

  • Risks Related to our Business
  • Our business, operating results, and cash flows have historically been affected and may continue to be adversely affected by inflation.
  • Our operating results depend in part on our ability to contain or reduce costs. There is substantial price competition in our industry and upward pressure on material and labor costs. Our success and profitability will depend on our ability to maintain a competitive cost and price structure.
  • The ongoing conflict between Russia and Ukraine, other similar conflicts and civil unrest in Haiti, which is in proximity to our manufacturing facilities in the Dominican Republic could have a material adverse effect on our business and results of operations.
  • We depend on a small number of customers for a large percentage of our net sales. The loss of any such customer, a reduction in net sales to any such customer, or the decline in the financial condition of any such customer could have a material adverse effect on our business, financial condition, and results of operations.
  • Our business could be harmed if our products contain undetected errors or defects or do not meet applicable specifications.
  • New technologies could result in the development of new products by our competitors and a decrease in demand for our products, which could materially adversely affect our business, financial condition and results of operations.
  • If we fail to comply with specific provisions of our customer contracts or Food and Drug Administration (FDA) regulations, our business could be materially adversely affected.
  • Increased focus and evolving views of lawmakers on climate change and other ESG issues could have a long-term impact on our business and result of operations.
  • Global climate change and related regulations and changes in customer demand could negatively affect our operations and our business.
  • We may pursue acquisitions or other strategic relationships that involve inherent risks, any of which may cause us to not realize anticipated benefits.
  • Failure to retain key personnel could impair our ability to execute our business strategy.
The other 24 risks
  • We operate in highly competitive industries, and we may be unable to compete successfully, which could materially adversely affect our business, financial condition and results of operations.
  • Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards, and other requirements may adversely impact our business and financial results.
  • Security breaches, including cybersecurity incidents and other disruptions could compromise our information, expose us to liability and harm our reputation and business.
  • We experienced a material information technology (“IT”) systems incident in February 2026, which could result in a number of potentially unknown outcomes, including but not limited to, litigation, regulatory investigations or enforcement actions, or reputational harm, any of which could have a material impact on our business operations, financial condition, or results of operations.
  • Disruptions in the supply of components and raw materials we use in manufacturing our products could cause production delays or reductions in the number of products we manufacture, which could materially adversely affect our business, financial condition, and results of operations.
  • If we fail to accurately forecast component and raw material requirements for our products, we could incur additional costs and experience significant delays in shipments, which could have an adverse effect on the results of our business operations, and could damage our relationships with customers.
  • We may be unable to protect our proprietary technology from infringement.
  • Our products could infringe the intellectual property rights of others, which may lead to litigation that could itself be costly, result in the payment of substantial damages or royalties, and prevent us from using technology that is essential to our products.
  • Reductions in the availability of energy supplies or an increase in energy costs may increase our operating costs.
  • Consolidation in the healthcare industry could result in greater competition and reduce our net sales and harm our business.
  • Our business is indirectly subject to healthcare industry cost containment and healthcare reform measures that could result in reduced sales of our products.
  • Expansion of our operations into markets outside of the U.S. subjects us to political, economic, legal, operational, and other risks that could have a material adverse effect on our business, results of operations, financial condition, cash flows and reputation.
  • If significant tariffs or other restrictions are placed on imports or any related counter-measures are taken by foreign countries, our revenue and results of operations may be materially harmed. Potential changes in international trade relations between the United States and other countries could have a material adverse effect on our business.
  • We have incorporated and may further incorporate artificial intelligence (AI) into our internal operations to enhance employee productivity and improve cybersecurity. Implementation of artificial intelligence technologies may result in legal and regulatory risks, reputational harm, or other adverse consequences to our business.
  • Changes in foreign currency rates could have a material adverse effect on our financial position, results of operations, and cash flows.
  • Risks Related to our Share Ownership and our Capital Structure
  • Restrictions in our credit facilities may limit our business and financial activities, including our ability to obtain additional capital in the future.
  • Provisions of our corporate charter documents and Delaware law, may dissuade potential acquirers, prevent the replacement or removal of our current management, and may thereby affect the price of our common stock.
  • Financial Risks
  • Our operating results may fluctuate, which may make it difficult to forecast our future performance and may result in volatility in our stock price.
  • Our international sales and operations are subject to a variety of market and financial risks and costs that could affect our profitability and operating results.
  • We have a complex tax profile due to the global nature of our operations and may experience increases and variability in our quarterly and annual effective tax rate due to several factors, including changes in the mix of pre-tax income and the jurisdictions to which it relates, business acquisitions, settlements with taxing authorities, and changes in tax rates.
  • We may never realize the full value of our intangible assets, which represent a significant portion of our total assets.
  • We have significant indebtedness that could adversely affect our operations, financial condition, and cash flows if we fail to meet certain financial covenants required by our debt agreements or if our access to capital markets is interrupted.
  • General Risks
  • We are subject to a variety of federal, state and local laws and regulations, including health and safety laws and regulations, and the cost of complying, or our failure to comply, with such requirements could materially adversely affect our business, financial condition and results of operations.
  • Our operations could be disrupted by natural or human causes beyond our control.

Legal proceedings

From time to time, the Company may be a party to various suits, claims and complaints arising in the ordinary course of business and is currently a party to a single employee claim. In the opinion of management of the Company, this active claim should not result in final judgments or settlements that, in the aggregate, would have a material adverse effect on the Company’s financial condition or results of operations.

The opening of Item 3, Legal Proceedings.17

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66